Process Validation of Oral Solid Dosage Form-Tablet containing Anti Tubercular Agent
Abstract
The purpose of study is to validate process of Rifampin 150mg and Isoniazid 75mg tablet and to create a robust formulation. The critical process parameter was identified with the help of optimization batches of process capability and evaluated by challenging specification. Three process validation batches of same size, manufacturing process, equipment & validation criteria was taken. The critical parameter involved in sifting, dry mixing, preparation of granulating agent, wet mixing, wet milling, drying, sizing, lubrication and compression stages were identified and evaluated. The outcome indicated that this process validation data provides high degree of assurance that manufacturing process produces product meeting its predetermined specifications and quality attributes.Keywords:
Rifampin, Isoniazid, Process validation, Uniformity of mixingReferences
1. http://www.fda.gov/cder/whatsnew.html
2. http://www.who guidelines.com
3. Nash R. A. and Wachter A. H. 2003 Pharmaceutical Process Validation, New York: Marcel Dekkar, Inc.
4. Monohar A Potdar, 2007 “Pharmaceutical Quality Assurance" Pune: Nirali Prakashan.
5. Sindhur nag N, Gouthami B, Madhuri L, Lavanyareddy V, Krishnaveni N, Meyyanathan S N, Suresh .2012 The concept of process validation in tablet manufacturing: Journal of Pharmacy Rsearch. 4(2). 1264-1267.
6. Sravani Shilpa.K, Meka Anand Kumar and Senthil Kumar.M. 2011, Formulation and Process Validation of Clopidogrel Bisulfate 300mg Tablet. International Journal of Pharmaceutical Quality Assurance. 3(4):1-14.
7. Current Good Manufacturing Practice for finished Pharmaceuticals. Code of Federal Regulations, Part 211, Office of Federal Register National Archives and Records Administration, Washington DC, USA, 1989
8. P.P. Sharma, 2010 "How To Practice GMP A Treatise On GMP" Mumbai: Vandana Publication.
9. Indian Pharmacopoeia 2007 Volume 3 government of Indian ministry of health and family welfare published by the Indian pharmacopoeia commission, Ghaziabad
10. Indian Pharmacopoeia 2007 Volume 1 government of Indian ministry of health and family welfare published by the Indian pharmacopoeia commission, Ghaziabad
11. S. layer, 2003 Guidelines on cGMP and Quality of Pharmaceutical Product, Mumbai: D.K Publication
Published
Abstract Display: 0
PDF Downloads: 0